Related Experiment Video
Updated: May 28, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity
Nicolas Léveillé1, Ran Elkon, Veronica Davalos
1Division of Gene Regulation, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Abstract:
MicroRNAs (miRNAs) interact with 3'-untranslated regions of messenger RNAs to restrict expression of most protein-coding genes during normal development and cancer. RNA-binding proteins (RBPs) can control the biogenesis, stability and activity of miRNAs. Here we identify RBM38 in a genetic screen for RBPs whose expression controls miRNA access to target mRNAs. RBM38 is induced by p53 and its ability to modulate miRNA-mediated repression is required for proper p53 function. In contrast, RBM38 shows lower propensity to block the action of the p53-controlled miR-34a on SIRT1. Target selectivity is determined by the interaction of RBM38 with uridine-rich regions near miRNA target sequences. Furthermore, in large cohorts of human breast cancer, reduced RBM38 expression by promoter hypermethylation correlates with wild-type p53 status. Thus, our results indicate a novel layer of p53 gene regulation, which is required for its tumour suppressive function.
Insights
RNA-binding protein RBM38 regulates microRNA (miRNA) activity, crucial for p53 tumor suppressor function. Reduced RBM38 in breast cancer links to wild-type p53, revealing a new gene regulation layer.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression, interacting with messenger RNA 3'-untranslated regions.
- RNA-binding proteins (RBPs) influence miRNA biogenesis, stability, and activity, impacting gene regulation.
- The tumor suppressor protein p53 regulates numerous cellular processes, including development and cancer.
Purpose of the Study:
- To identify RBPs that control miRNA access to target mRNAs.
- To elucidate the role of RBM38 in p53-mediated gene regulation and its impact on miRNA activity.
- To investigate the clinical relevance of RBM38 expression in human breast cancer.
Main Methods:
- Genetic screening to identify RBPs affecting miRNA-mRNA interactions.
- Assays to determine RBM38's effect on miRNA-mediated repression.
- Analysis of RBM38-miRNA target sequence interactions.
- Correlation analysis of RBM38 expression, promoter hypermethylation, and p53 status in human breast cancer cohorts.
Main Results:
- RBM38 was identified as an RBP that modulates miRNA-mediated repression.
- RBM38's activity is induced by p53 and is essential for p53 function.
- RBM38 selectively interacts with uridine-rich regions near miRNA target sites, influencing target accessibility.
- Reduced RBM38 expression due to promoter hypermethylation correlates with wild-type p53 in breast cancer patients.
Conclusions:
- RBM38 represents a novel regulatory mechanism in p53-mediated gene expression.
- RBM38's modulation of miRNA activity is critical for the tumor suppressive functions of p53.
- Dysregulation of RBM38 in breast cancer may contribute to tumorigenesis, particularly in tumors with wild-type p53.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage can Stall the Cell Cycle
